Cargando…
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries
BACKGROUND AND AIMS: No drugs are currently approved for Coronavirus Disease-2019 (COVID-19), although some have been tried. In view of recent studies and discussion on chloroquine and hydroxychloroquine (HCQ), we aimed to review existing literature and relevant websites regarding these drugs and CO...
Autores principales: | Singh, Awadhesh Kumar, Singh, Akriti, Shaikh, Altamash, Singh, Ritu, Misra, Anoop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102587/ https://www.ncbi.nlm.nih.gov/pubmed/32247211 http://dx.doi.org/10.1016/j.dsx.2020.03.011 |
Ejemplares similares
-
“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020) -
Letter in response to letter to the editor by Singh and Dhibar regarding the article “COVID-19: From bench to bedside” (Singh et al.)
por: Singh, Akriti, et al.
Publicado: (2020) -
COVID-19: From bench to bed side
por: Singh, Akriti, et al.
Publicado: (2020) -
Molnupiravir in COVID-19: A systematic review of literature
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021) -
Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)